Roche Holding AG (RHHBY) is a publicly traded company in the Healthcare sector, operating within the Drug Manufacturers - General industry. The company is headquartered in Basel, Switzerland. The current CEO is Thomas Schinecker.
RHHBY has IPO date of 2003-08-20, 103,249 full-time employees, listed on the Other OTC, a market capitalization of $328.61B.
Roche Holding AG is a Swiss multinational pharmaceutical and diagnostics company founded in 1896 and headquartered in Basel. The company develops and markets pharmaceutical products across multiple therapeutic areas including oncology, neuroscience, immunology, cardiovascular and metabolism, ophthalmology, and respiratory diseases, as well as treatments for conditions such as cancer, hemophilia, and inflammatory disorders. In addition to pharmaceuticals, Roche operates a substantial diagnostics business offering in vitro tests for disease diagnosis including cancer, diabetes, COVID-19, and hepatitis, alongside diagnostic instruments and reagents. The company serves patients and healthcare providers across Switzerland, Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and numerous other markets globally.
